SP0993, NCT01243177 / 2010-019765-28: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older |
|
|
| Completed | 3 | 888 | Europe, Canada, Japan, US, RoW | Lacosamide, Vimpat®, Carbamazepine-Controlled Release, Tegretol® Retard Tablets 200 mg | UCB BIOSCIENCES GmbH, Eden Sarl | Epilepsy, Monotherapy | 07/15 | 08/15 | | |
